Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma

AIM: This study aimed to explore the expression pattern of MLLT11 under different pathological features, evaluate its prognostic value for glioma patients, reveal the relationship between MLLT11 mRNA expression and immune cell infiltration in the tumor microenvironment (TME), and provide more eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Long, Xiong, Zujian, Zhao, Hongyu, Teng, Chubei, Liu, Hongwei, Huang, Qi, Wanggou, Siyi, Li, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414891/
https://www.ncbi.nlm.nih.gov/pubmed/36033495
http://dx.doi.org/10.3389/fonc.2022.889351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414891/
https://www.ncbi.nlm.nih.gov/pubmed/36033495
http://dx.doi.org/10.3389/fonc.2022.889351

Ejemplares similares